Report - ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS · 4 Hepatic impairment Kinzalkombshould not be given to patients with cholestasis, biliary obstructive disorders or severe hepatic insufficiency

Select PornographicDefamatoryIllegal/UnlawfulSpamOther Terms Of Service ViolationFile a copyright complaint

Please pass captcha verification before submit form